The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
l-Thyroxine vs. 3,5,3′-triiodo-l-thyronine and cell proliferation: activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase
Abstract
3,5,3′-Triiodo-l-thyronine (T 3), but not l-thyroxine (T 4), activated Src kinase and, downstream, phosphatidylinositol 3-kinase (PI3-kinase) by means of an α v β 3 integrin receptor on human glioblastoma U-87 MG cells. Although both T 3 and T 4 stimulated extracellular signal-regulated kinase (ERK) 1/2, activated ERK1/2 did not contribute to T 3-induced Src kinase or PI3-kinase activation, and an inhibitor of PI3-kinase, LY-294002, did not block activation of ERK1/2 by physiological concentrations of T 3 and T 4. Thus the PI3-kinase, Src kinase, and ERK1/2 signaling cascades are parallel pathways in T 3-treated U-87 MG cells. T 3 and T 4 both caused proliferation of U-87 MG cells; these effects were blocked by the ERK1/2 inhibitor PD-98059 but not by LY-294002. Small-interfering RNA knockdown of PI3-kinase confirmed that PI3-kinase was not involved in the proliferative action of T 3 on U-87 MG cells. PI3-kinase-dependent actions of T 3 in these cells included shuttling of nuclear thyroid hormone receptor-α (TRα) from cytoplasm to nucleus and accumulation of hypoxia-inducible factor ( HIF)- 1α mRNA; LY-294002 inhibited these actions. Results of studies involving α v β 3 receptor antagonists tetraiodothyroacetic acid (tetrac) and Arg-Gly-Asp (RGD) peptide, together with mathematical modeling of the kinetics of displacement of radiolabeled T 3 from the integrin by unlabeled T 3 and by unlabeled T 4, are consistent with the presence of two iodothyronine receptor domains on the integrin. A model proposes that one site binds T 3 exclusively, activates PI3-kinase via Src kinase, and stimulates TRα trafficking and HIF- 1α gene expression. Tetrac and RGD peptide both inhibit T 3 action at this site. The second site binds T 4 and T 3, and, via this receptor, the iodothyronines stimulate ERK1/2-dependent tumor cell proliferation. T 3 action here is inhibited by tetrac alone, but the effect of T 4 is blocked by both tetrac and the RGD peptide.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PI3K: Downstream AKTion Blocks Apoptosis
Franke, T. F., Kaplan, D. R., & Cantley, L. C. (1997) · Cell · doi:10.1016/s0092-8674(00)81883-8 · Cited by 1,668
Plow, E. F., Haas, T. A., Zhang, L., Loftus, J., & Smith, J. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.r000003200 · Cited by 1,356
Bergh, J. J., Lin, H.-Y., Lansing, L., Mohamed, S. N., Davis, F. B., Mousa, S., & Davis, P. J. (2005) · Endocrinology · doi:10.1210/en.2005-0102 · Cited by 497
Self-citationJhawer, M., Goel, S., Wilson, A. J., Montagna, C., Ling, Y.-H., Byun, D.-S., Nasser, S., Arango, D., Shin, J., Klampfer, L., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5659 · Cited by 460
Rapid nongenomic actions of thyroid hormone
Hiroi, Y., Kim, H.-H., Ying, H., Furuya, F., Huang, Z., Simoncini, T., Noma, K., Ueki, K., Nguyen, N.-H., Scanlan, T. S., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601600103 · Cited by 380
Mechanisms of nongenomic actions of thyroid hormone
Davis, P. J., Leonard, J. L., & Davis, F. B. (2008) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2007.09.003 · Cited by 363
Self-citationPI3K/PTEN signaling in tumorigenesis and angiogenesis
Jiang, B.-H., & Liu, L.-Z. (2008) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2007.09.008 · Cited by 345
Thyroid hormone induces activation of mitogen-activated protein kinase in cultured cells
Lin, H.-Y., Davis, F. B., Gordinier, J. K., Martino, L. J., & Davis, P. J. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.276.5.c1014 · Cited by 239
Self-citationIsolation and characterization of cancer stem cells from a human glioblastoma cell line U87
Yu, S.-C., Ping, Y.-F., Yi, L., Zhou, Z.-H., Chen, J.-H., Yao, X.-H., Gao, L., Wang, J. M., & Bian, X.-W. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.02.010 · Cited by 237
Davis, F. B., Mousa, S. A., O’Connor, L., Mohamed, S., Lin, H.-Y., Cao, H. J., & Davis, P. J. (2004) · Circulation Research · doi:10.1161/01.res.0000130784.90237.4a · Cited by 225
Self-citationNongenomic Actions of Thyroid Hormone on the Heart
Davis, P. J., & Davis, F. B. (2002) · Thyroid · doi:10.1089/105072502760143827 · Cited by 223
Self-citationThyroid hormone action at the cellular, genomic and target gene levels
Yen, P. M., Ando, S., Feng, X., Liu, Y., Maruvada, P., & Xia, X. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.11.030 · Cited by 216
Tang, H.-Y., Lin, H.-Y., Zhang, S., Davis, F. B., & Davis, P. J. (2004) · Endocrinology · doi:10.1210/en.2004-0308 · Cited by 216
Self-citationMembrane receptors mediating thyroid hormone action
Davis, P. J., Davis, F. B., & Cody, V. (2005) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2005.09.007 · Cited by 178
Self-citationActing via a Cell Surface Receptor, Thyroid Hormone Is a Growth Factor for Glioma Cells
Davis, F. B., Tang, H.-Y., Shih, A., Keating, T., Lansing, L., Hercbergs, A., Fenstermaker, R. A., Mousa, A., Mousa, S. A., Davis, P. J., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4365 · Cited by 177
Self-citationMoeller, L. C., Cao, X., Dumitrescu, A. M., Seo, H., & Refetoff, S. (2006) · Nuclear Receptor Signaling · doi:10.1621/nrs.04020 · Cited by 153
Moeller, L. C., Dumitrescu, A. M., & Refetoff, S. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0542 · Cited by 149
Nuclear Cytoplasmic Shuttling by Thyroid Hormone Receptors
Baumann, C. T., Maruvada, P., Hager, G. L., & Yen, P. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011112200 · Cited by 149
αvβ3 and αvβ5 integrins control glioma cell response to ionising radiation through ILK and RhoB
Monferran, S., Skuli, N., Delmas, C., Favre, G., Bonnet, J., Moyal, E. C., & Toulas, C. (2008) · International Journal of Cancer · doi:10.1002/ijc.23498 · Cited by 148
Activation of phosphatidylinositol 3-kinase signaling by a mutant thyroid hormone β receptor
Furuya, F., Hanover, J. A., & Cheng, S.-Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510849103 · Cited by 147
Rapid signaling at the plasma membrane by a nuclear receptor for thyroid hormone
Storey, N. M., Gentile, S., Ullah, H., Russo, A., Muessel, M. J., Erxleben, C. F. J., & Armstrong, D. L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600089103 · Cited by 135
Lin, H., Tang, H., Keating, T., Wu, Y.-H., Shih, A., Hammond, D., Sun, M., Hercbergs, A. A., Davis, F. B., & Davis, P. J. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm239 · Cited by 128
Self-citationThyroid Hormone Promotes Serine Phosphorylation of p53 by Mitogen-Activated Protein Kinase
Shih, A., Lin, H., Davis, F. B., & Davis, P. J. (2001) · Biochemistry · doi:10.1021/bi001978b · Cited by 122
Self-citationTang, H.-Y., Shih, A., Cao, H., Davis, F. B., Davis, P. J., & Lin, H. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0216 · Cited by 120
Self-citationMolecular modeling of the thyroid hormone interactions with αvβ3 integrin
Cody, V., Davis, P. J., & Davis, F. B. (2006) · Steroids · doi:10.1016/j.steroids.2006.11.008 · Cited by 106
Self-citationLin, H., Shih, A., Davis, F. B., & Davis, P. J. (1999) · Biochemical Journal · doi:10.1042/bj3380427 · Cited by 99
Self-citationLei, J., Mariash, C. N., & Ingbar, D. H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405497200 · Cited by 94
Thyroxine-dependent regulation of integrin-laminin interactions in astrocytes
Farwell, A. P., Tranter, M. P., & Leonard, J. L. (1995) · Endocrinology · doi:10.1210/endo.136.9.7649099 · Cited by 93
Lei, J., Mariash, C. N., Bhargava, M., Wattenberg, E. V., & Ingbar, D. H. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00335.2007 · Cited by 83
Lin, H., Zhang, West, B. L., Tang, H.-Y., Passaretti, T. V., Davis, F. B., & Davis, P. J. (2003) · Biochemistry · doi:10.1021/bi0273967 · Cited by 69
Self-citationLi, X., Kimbrel, E. A., Kenan, D. J., & McDonnell, D. P. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.7.0860 · Cited by 61
Integrin αvβ3 Controls Activity and Oncogenic Potential of Primed c-Src
Huveneers, S., van den Bout, I., Sonneveld, P., Sancho, A., Sonnenberg, A., & Danen, E. H. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3654 · Cited by 60
Potentiation by Thyroid Hormone of Human IFN-γ-Induced HLA-DR Expression
Lin, H., Martino, L. J., Wilcox, B. D., Davis, F. B., Gordinier, J., & Davis, P. J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.2.843 · Cited by 56
Self-citationAlenghat, T., Yu, J., & Lazar, M. A. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601280 · Cited by 54
Potentiation by thyroid hormone of human IFN-gamma-induced HLA-DR expression.
Lin, H., Martino, L. J., Wilcox, B. D., Davis, F. B., Gordinier, J., & Davis, P. J. (1998) · PubMed · Cited by 53
Self-citationBlum, R., Jacob‐Hirsch, J., Rechavi, G., & Kloog, Y. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0193 · Cited by 45
Kim, K., Brush, J. M., Watson, P. A., Cacalano, N. A., Iwamoto, K. S., & McBride, W. H. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-07-0313 · Cited by 30
Lombardi, A., Lanni, A., de Lange, P., Silvestri, E., Grasso, P., Senese, R., Goglia, F., & Moreno, M. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.11.073 · Cited by 28
Thyroid Hormones: Rapid Reply by Surface Delivery Only
Incerpi, S. (2005) · Endocrinology · doi:10.1210/en.2005-0394 · Cited by 22
Self-citationGordon, A., Swartz, H., & Shwartz, H. (2006) · Thyroid · doi:10.1089/thy.2006.16.521 · Cited by 12
Cited by
Thyroid Hormone Regulation of Metabolism
Mullur, R., Liu, Y.-Y., & Brent, G. A. (2014) · Physiological Reviews · doi:10.1152/physrev.00030.2013 · Cited by 2,421
Molecular Aspects of Thyroid Hormone Actions
Cheng, S.-Y., Leonard, J. L., & Davis, P. J. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0007 · Cited by 1,384
Self-citationNongenomic actions of thyroid hormone
Davis, P. J., Goglia, F., & Leonard, J. L. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.205 · Cited by 465
Self-citationThyroid Hormones as Modulators of Immune Activities at the Cellular Level
De Vito, P., Incerpi, S., Pedersen, J. Z., Luly, P., Davis, F. B., & Davis, P. J. (2011) · Thyroid · doi:10.1089/thy.2010.0429 · Cited by 347
“Immunomodulatory consequences of stimulating PI3K include activation of myeloid cell leukemia-1 (153) and expression of the hypoxia-inducible factor-1a (HIF-1a) gene (36).”
Self-citationThyroid hormone, thyroid hormone receptors, and cancer: a clinical perspective
Moeller, L. C., & Führer, D. (2013) · Endocrine-Related Cancer · doi:10.1530/erc-12-0219 · Cited by 184
Metadata
- Authors
- Lin, H.-Y., Sun, M., Tang, H.-Y., Lin, C., Luidens, M. K., Mousa, S. A., Incerpi, S., Drusano, G. L., Davis, F. B., & Davis, P. J.
- Venue
- American Journal of Physiology-Cell Physiology
- Publisher
- American Physiological Society
- Published
- 2009-05
- Volume
- 296
- Issue
- 5
- Pages
- C980-C991
- ISSN
- 0363-6143 (ISSN-L)
- 1522-1563
- OpenAlex
- W2168528745
- Cited by
- 255
- References
- 40
- FWCI
- 12.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.